Analysis of blood donors’ characteristics during third-peak COVID-19 in Bojonegoro Regency, Indonesia

https://doi.org/10.22146/jcoemph.80232

siti - nurkasanah(1*)

(1) DIII Blood Bank Technology, STIKES Rajekwesi, Bojonegoro
(*) Corresponding Author

Abstract


The third peak of the Coronavirus Disease 2019 (COVID-19) in Indonesia which was recorded on February-March 2022 had an impact on voluntary blood donations at the Indonesian Red Cross (IRCS) Bojonegoro. The objective of this research was to analyze the voluntary blood donors’ characteristics during the third COVID-19 peak in Bojonegoro Regency. This descriptive, analytical study was conducted using secondary blood donor data from February 22, 2022 to March 19, 2022 at IRCS Bojonegoro. The data were collected in the blood donor selection process in accordance with the Indonesian and World Health Organization (WHO) blood donor selection guidelines. The average number of voluntary blood donors per day was tested using the Mann-Whitney-U test with a significance ofp<0.05. The results showed 219 people (80.51%) between 22-28 February and 332 people (83.63%) between 1-19 March 2022 who were approved to donate at IRCS Bojonegoro. There was a significant decrease in the average of male voluntary blood donors per day (p=0.01),average age group: 17-24 years (p=0.013), 35-44 years (p=0.002), and 45-54 years (p=0.030), hemoglobin (Hbl) levels on 16.1-17.0 g/dL (p=0.000), systolic blood pressure (SBP) <120 (p=0.03) and 130-139 (p= 0.02) and diastolic blood pressure (DBP) <80 (p=0.001), pulse rate (PR) 65-74 beats/minute (p=0.016), and blood type O+ (p=0.008). The characteristics of voluntary blood donors during the third peak of COVID-19 in Bojonegoro Regency indicated there was a significantly decreased number of male voluntary blood donors per day around ages 17-24 and 35-54 years, with Hbl between 16.1-17.0 g/dL, SBP <120 and 130-139 mmHg, DBP <80 mmHg, PR 65-74 beats/minute, body weight 45-54 and 65-74 kg, and blood type O+.


Keywords


Characteristic; Indonesian Red Cross Society; selection donor process; third-peak of COVID-19; voluntary blood donor

Full Text:

PDF


References

1.Bogoch II, Watts A, Thomas-Bachli A, Huber C, Kraemer MUG, Khan K. Pneumonia of unknown aetiology in Wuhan, China: potential for international spread via commercial air travel. J Travel Med. 2020;27(2):1-3. DOI: 10.1093/jtm/taaa008.

2.Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8(5):475-481. DOI: 10.1016/S2213-2600(20)30079-5.

3.Cucinotta D, Vanelli M. WHO Declares COVID-19 a Pandemic. Acta Biomed. 2020;91(1):157-160. DOI: 10.23750/abm.v91i1.9397.

4.WHO Indonesia Situation Report. Coronavirus Disease 2019 (COVID-19) Situation Report – 88 [Internet]. [Updated 16 March 2022; cited 28 August 2022]. Available from: http://www.who.int/indonesia.

5.Sigal A, Milo R, Jassat W. Estimating disease severity of Omicron and Delta SARS-CoV-2 infections. Nat Rev Immunol. 2022;22(5):267-269. DOI: 10.1038/s41577-022-00720-5.

6.Arora T, Grey I. Health behaviour changes during COVID-19 and the potential consequences: A mini-review. J Health Psychol. 2020;25(9):1155-1163. DOI: 10.1177/1359105320937053.

7.Jordan S, Starker A, Krug S, Manz K, Moosburger R, Schienkiewitz A, et al. Health behaviour and COVID-19: Initial findings on the pandemic. J Health Monit. 2020;5(8):2-14. DOI: 10.25646/7055

8.Tripathi PP, Kumawat V, Patidar GK. Donor’s Perspectives on Blood Donation During COVID-19 Pandemic. Indian J Hematol Blood Transfus. 2022;38(3):536-545. DOI: 10.1007/s12288-021-01504-y.

9.PERMENKES. Peraturan Menteri Kesehatan Republik Indonesia Nomor 91 tahun 2015: Standar Pelayanan Transfusi Darah [Internet]. Jakarta: Kementerian Kesehatan Republik Indonesia; 2015. [cited 28 August 2022]. Available from: https://peraturan.bpk.go.id/Home/Details/116661/permenkes-no-91-tahun-2015

10.World Health Organization. COVID-19 weekly Epidemiological Update Edition 80 – 81 [Internet]. [Updated 22 February and 1 March 2022; cited 11 January 2023]. Available from: https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19---22-february-2022 and https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19---1-march-2022

11.Susanto AP, Findyartini A, Taher A, Susilaradeya DP, Ariawan I, Dartanto T, et al. COVID-19 in Indonesia: Challenges and Multidisciplinary Perspectives for a Safe and Productive New Normal. Acta Med Indones. 2020;52(4):423-430. PMID: 33377888.

12.Kumar S, Azim D, Nasim S, Hashmi SH. Dwindling blood reserves: An ominous downside of COVID-19 pandemic. Transfus Apher Sci. 2020;59(5):102818. DOI: 10.1016/j.transci.2020.102818.

13.International Labour Organization. Decent Work Country Profile Indonesia. International Labour Organization. 2011. [Cited 28 August 2022]. Available from: https://www.ilo.org/wcmsp5/groups/public/---dgreports/---integration/documents/publication/wcms_167418.pdf

14.Clement M, Shehu E, Chandler T. The impact of temporary deferrals on future blood donation behavior across the donor life cycle. Transfusion. 2021;61(6):1799-1808. DOI: 10.1111/trf.16387.

15.Selvaraj A, Radhin V, Ka N, Benson N, Mathew AJ. Effect of pandemic based online education on teaching and learning system. Int J Educ Dev. 2021;85:102444. DOI: 10.1016/j.ijedudev.2021.102444.

16.Rafiee MH, Kafiabad SA, Maghsudlu M. Analysis of blood donors’ characteristics and deferrals related to COVID-19 in Iran. Transfus Apher Sci. 2021;60(2):103049. DOI: 10.1016/j.transci.2020.103049.

17.Hutajulu RS. Evaluating the Impact of “Work from Home Policy” on Job Performance (Study Case in Indonesia). International Journal of Indonesian Society and Culture 2021;13(1):39-50. DOI: 10.15294/komunitas.v13i1.28436

18.Gkirtsou C, Konstantinidis T, Cassimos D, Konstantinidou EI, Kontekaki EG, Rekari V, et al. Views and Attitudes of Blood Donors toward Blood Donation during the COVID-19 Pandemic in Thrace Region, Greece. Int J Environ Res Public Health. 2022;19(9):4963. DOI: 10.3390/ijerph19094963.

19.Chowdhury SF, Anwar S. Management of Hemoglobin Disorders During the COVID-19 Pandemic. Front Med (Lausanne). 2020;7:306. DOI: 10.3389/fmed.2020.00306.

20.Food and Drug Administration, HHS. Requirements for blood and blood components intended for transfusion or for further manufacturing use. Final rule. Fed Regist 2015; 80(99): 29841-906. PMID: 26003966.

21.Dasgupta K, Quinn RR, Zarnke KB, Rabi DM, Ravani P, Daskalopoulou SS, et al. The 2014 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. Can J Cardiol. 2014;30(5):485-501. DOI: 10.1016/j.cjca.2014.02.002.

22.American Heart Association (AHA). All About Heart Rate (Pulse) [Internet]. 2022. [Cited 28 August 2022]. Available from: https://www.heart.org/en/health-topics/high-blood-pressure/the-facts-about-high-blood-pressure/all-about-heart-rate-pulse.

23.Franchini M, Favaloro EJ, Targher G, Lippi G. ABO blood group, hypercoagulability, and cardiovascular and cancer risk. Crit Rev Clin Lab Sci. 2012;49(4):137-49. DOI: 10.3109/10408363.2012.708647.

24.Patidar GK, Dhiman Y. Distribution of ABO and Rh (D) Blood groups in India: A systematic review.2021;16:37-48. DOI: 10.1111/voxs.12576

25.Veseli B, Sandner S, Studte S, Clement M. The impact of COVID-19 on blood donations. PLoS One. 2022;17(3):e0265171. DOI: 10.1371/journal.pone.0265171.

26.Shehu E, Hofmann A, Clement M, Langmaack AC. Healthy donor effect and satisfaction with health: The role of selection effects related to blood donation behavior. Eur J Health Econ. 2015;16(7):733-45. DOI: 10.1007/s10198-014-0625-1.



DOI: https://doi.org/10.22146/jcoemph.80232

Article Metrics

Abstract views : 1448 | views : 705

Refbacks

  • There are currently no refbacks.


Copyright (c) 2023 Journal of Community Empowerment for Health

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.